Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Inventory Average (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Inventory Average for 16 consecutive years, with $490.9 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 13.37% to $490.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $490.9 million through Dec 2025, up 13.37% year-over-year, with the annual reading at $460.9 million for FY2025, 12.6% up from the prior year.
  • Inventory Average hit $490.9 million in Q4 2025 for Integra Lifesciences Holdings, up from $477.1 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $490.9 million in Q4 2025 to a low of $315.6 million in Q3 2022.
  • Historically, Inventory Average has averaged $376.7 million across 5 years, with a median of $356.5 million in 2023.
  • Biggest five-year swings in Inventory Average: fell 6.48% in 2021 and later rose 19.17% in 2024.
  • Year by year, Inventory Average stood at $322.3 million in 2021, then decreased by 1.38% to $317.8 million in 2022, then grew by 18.91% to $377.9 million in 2023, then increased by 14.57% to $433.0 million in 2024, then increased by 13.37% to $490.9 million in 2025.
  • Business Quant data shows Inventory Average for IART at $490.9 million in Q4 2025, $477.1 million in Q3 2025, and $455.3 million in Q2 2025.